NPR3 Gene - Natriuretic Peptide Receptor 3
NPR3: A key regulator of natriuretic peptide clearance and cardiovascular homeostasis
Gene Information Card
| Symbol | NPR3 |
|---|---|
| Full Name | Natriuretic Peptide Receptor 3 |
| Gene Type | protein-coding |
| Chromosomal Location | 5p13.3 |
| NCBI Gene ID | 4883 ncbi.nlm.nih.gov/gene/4883 |
| Ensembl ID | ENSG00000113389 |
| UniProt ID | P17342 |
| OMIM ID | 108962 |
| HGNC ID | 7944 |
| Aliases | NPR-C, ANPRC, GUCY2B, NPRC, ANP-C, ANPR-C |
Description
NPR3 encodes the natriuretic peptide receptor 3 (NPR-C), a clearance receptor for atrial (ANP), brain (BNP), and C-type (CNP) natriuretic peptides. Unlike NPR1 and NPR2, NPR3 lacks guanylyl cyclase activity and primarily functions to internalize and degrade natriuretic peptides, thereby regulating their local and circulating concentrations. The receptor is widely expressed in vascular smooth muscle, endothelium, kidney, bone, and adipose tissue. NPR3 also mediates G-protein-coupled signaling independent of cGMP, influencing cell proliferation, fibrosis, and bone growth. Loss-of-function mutations in NPR3 are associated with bone overgrowth and blood pressure variation.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Osteoporosis (bone mineral density variation) | NPR3 variants alter CNP clearance, affecting bone growth and remodeling | GWAS (NCBI Gene, OMIM) |
| Hypertension (blood pressure regulation) | NPR3 modulates natriuretic peptide levels, influencing vascular tone and sodium excretion | ClinVar, OMIM |
| Short stature / skeletal dysplasia | Loss-of-function mutations reduce CNP clearance, leading to impaired endochondral ossification | OMIM #108962, ClinVar |
| Heart failure | Altered NPR3 expression affects BNP/ANP clearance, impacting cardiac stress response | NCBI Gene, UniProt |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose tissue | 12.5 | Medium |
| Kidney | 15.3 | Medium |
| Lung | 18.7 | Medium |
| Heart | 8.2 | Low |
| Bone (osteoblasts) | 20.1 | High |
| Vascular smooth muscle | 22.4 | High |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 14.5 | Moderate expression |
| A549 (lung) | 19.8 | High expression |
| HUVEC (endothelial) | 25.3 | Very high expression |
| Saos-2 (osteosarcoma) | 21.0 | High expression |
| MCF7 (breast) | 6.2 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1102C>T (p.Arg368*) | Nonsense | <0.01% | Loss of function; associated with skeletal overgrowth |
| c.1573G>A (p.Val525Met) | Missense | 0.02% | Reduced ligand binding; possible blood pressure effect |
| c.2021_2022del (p.Leu674fs) | Frameshift | <0.01% | Loss of function; bone dysplasia |
| c.44G>A (p.Arg15His) | Missense | 0.05% | Unknown significance; reported in ClinVar |
Mutation functional classification
Loss of Function (LOF)
Nonsense and frameshift mutations (e.g., p.Arg368*, p.Leu674fs) truncate the receptor, impairing natriuretic peptide clearance and leading to elevated CNP levels, which disrupts bone growth.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported in NPR3.
Dominant Negative (DN)
Not described for NPR3; the receptor functions as a homodimer, but dominant-negative effects have not been documented.
View complete mutation data:
Gene Ontology (GO)
| • GO:0004888 - transmembrane signaling receptor activity | • GO:0005524 - ATP binding |
| • GO:0007165 - signal transduction | • GO:0016021 - integral component of membrane |
| • GO:0035378 - natriuretic peptide receptor activity | • GO:0042802 - identical protein binding |
| • GO:0043403 - skeletal system development | • GO:0002024 - vasodilation |
Pathways
• Natriuretic peptide signaling pathway (Reactome: R-HSA-418594)
• cGMP-PKG signaling pathway (KEGG: hsa04022)
• Regulation of blood pressure (KEGG: hsa04924)
• Bone remodeling (Reactome: R-HSA-8878166)
Protein Summary
Natriuretic peptide receptor 3 (NPR-C) is a 540-amino acid transmembrane protein encoded by NPR3. It consists of a large extracellular ligand-binding domain, a single transmembrane helix, and a short intracellular tail lacking guanylyl cyclase activity. The receptor binds ANP, BNP, and CNP with high affinity and mediates their internalization and lysosomal degradation. NPR-C also couples to Gi/o proteins to inhibit adenylyl cyclase and activate phospholipase C, modulating cell proliferation and fibrosis. The protein is heavily N-glycosylated and forms homodimers. Its expression in bone, vasculature, and kidney underpins its roles in skeletal growth, blood pressure regulation, and fluid homeostasis.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NPR3 Knockout HEK293 Cell Line | EDJ-KQ14483 | Human | 4883 | Details Get a Quote |
| NPR3 Knockout A-549 Cell Line | EDJ-KQ44743 | Human | 4883 | Details Get a Quote |
| NPR3 Knockout HeLa Cell Line | EDC90131 | Human | 4883 | Details Get a Quote |
| NPR3 Knockout HCT 116 Cell Line | EDJ-KQ70977 | Human | 4883 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records